The upgrade in the price target by a reputable analyst like Akash Tewari from Jefferies is a strong positive signal for Apogee Therapeutics. It suggests a bullish outlook on the stock, likely due to underlying strengths or anticipated performance improvements. This can lead to increased investor confidence and potential upward movement in the stock price in the short term.